NY Genome Center

The New York Genome Center (NYGC) is a nonprofit academic research institution that is dedicated to advancing genomic research for neurodegenerative disease, neuropsychiatric disease, and cancer. As a multi-institutional hub for collaborative genomic research, NYGC leverages its strengths in technology development, computational biology, and whole-genome sequencing to drive scientific advancements and biomedical discoveries. Their areas of focus include the development of computational and experimental genomic methods, as well as disease-focused research to enhance the understanding of the genetic basis of cancer, neurodegenerative disease, and neuropsychiatric disease.

Additionally, NYGC has been actively involved in COVID-19 research, working closely with hospital and academic partners to monitor viral variants and explore the genetic factors contributing to severe disease. Committed to diversity, equity, and inclusion, NYGC promotes collaboration, innovation, and discovery. Learn more about NYGC’s commitment to diversity and inclusion on their website